secwatch / observer

8-K filed February 17, 2026, 6:59 PM ET ticker PAAC CIK 0002087446

other material confidence high sentiment neutral materiality 0.70

Proem Acquisition Corp I closes $130M IPO; trades on Nasdaq under PAACU

Proem Acquisition Corp. I

13,000,000 units sold at $10.00 each, gross proceeds $130M.
Each unit: one ordinary share and one-half warrant (exercise price $11.50).
Private placement: 292,500 private units to sponsor for $2.925M; 97,500 representative shares to Clear Street.
Four independent directors appointed: John Wu, David Eckstein, Amarnath Thombre, Andrey Kazakov.
Trust account funded with $130M; 24-month window for initial business combination.

item 1.01 item 3.02 item 5.02 item 5.03 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-016812
form_type: 8-K
ticker: PAAC
cik: 0002087446
company_name: Proem Acquisition Corp. I
filed_at: 2026-02-17T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.229911+00:00
generated_at: 2026-05-16T02:35:58.362471+00:00
sec_items: ["1.01", "3.02", "5.02", "5.03", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-016812
json_url: https://secwatch.observer/filing/0001213900-26-016812.json
markdown_url: https://secwatch.observer/filing/0001213900-26-016812.md
text_url: https://secwatch.observer/filing/0001213900-26-016812.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2087446/000121390026016812/0001213900-26-016812-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2087446/000121390026016812/ea0277151-8k_proem1.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

054ab9ff8e4676848df7cb0ed7fbb99b78df8ce1

Proem Acquisition Corp. I: Adopted Amended and Restated Memorandum and Articles of Association (effective 2026-02-11).

On February 11, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

04b9caeded9fb90382f8529de1305d13701563b4

Proem Acquisition Corp. I entered into Private Placement Units Purchase Agreement with Proem SPAC Partners I LLC (the "Sponsor") (effective 2026-02-11).

● Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference; ● Administrative Services Agreement,

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

0dbdc3e0acc159040fe4ac561a8d0fe25da02869

Proem Acquisition Corp. I entered into Registration Rights Agreement with the Sponsor and certain security holders of the Company (effective 2026-02-11).

Registration Rights Agreement, dated February 11, 2026, by and among the Company, the Sponsor and certain security holders of the Company

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

1287892ca278ca8506764282527f0df2c1df0a78

Proem Acquisition Corp. I entered into Underwriting Agreement with Clear Street LLC (effective 2026-02-11).

Underwriting Agreement, dated February 11, 2026, by and between the Company and Clear Street LLC, as representative of the underwriters in the IPO (“Clear Street”)

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

72806dcec44784017ccfca5ba7b4cf278240ba02

Proem Acquisition Corp. I entered into Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-11).

Warrant Agreement, dated February 11, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

d09ffb27ac174ac0124648cc170bd638abf74b63

Proem Acquisition Corp. I entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-11).

Investment Management Trust Agreement, dated February 11, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On February 11, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.

Filing page SEC filing

SAGU

Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE

Shreya Acquisition Group May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On February 11, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On February 11, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.

Filing page SEC filing

CLRB

Cellectar raises ~$35M via stock/warrant offering; reports positive 12-mo Phase 2b WM data

Cellectar Biosciences, Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 8.01, 9.01 same event type: other_material similar materiality

This filing

● Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference; ● Administrative Services Agreement,

Comparable filing

pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement”

Filing page SEC filing

PSEC

Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares

PROSPECT CAPITAL CORP May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 9.01 same event type: other_material similar materiality

This filing

On February 11, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.

Filing page SEC filing

ADT

Apollo sells all 102M ADT shares; ADT repurchases 29.1M shares in $1.5B plan

ADT Inc. May 8, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On February 11, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 8, 2026, the Board approved an amendment and restatement of the Company’s Amended and Restated Bylaws, dated as of September 15, 2023 (as amended, the “ Bylaws ”), to remove references related to Apollo and the Amended and Restated Stockholders Agreement, dated December 14, 2018, between the Company, Prime Security Services TopCo Parent, L.P., and the Co-Investors.

Filing page SEC filing

TPST

Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73

Tempest Therapeutics, Inc. June 1, 2026, 7:13 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

● Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference; ● Administrative Services Agreement,

Comparable filing

On May 28, 2026, Tempest Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into a warrant exercise and inducement offer letter agreement (the “ Inducement Letter ”) with a holder of certain existing warrants to purchase shares of the Company’s common stock

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 8.01, 9.01 same event type: other_material similar materiality

This filing

● Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference; ● Administrative Services Agreement,

Comparable filing

On May 28, 2026, Karman Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the persons named in Schedule II thereto (the “Selling Stockholders”) and Citigroup Global Markets Inc. and Evercore Group L.L.C., as the underwriters (the “Underwriters”), pursuant to which the Selling Stockholders agreed to sell 14,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a public offering price of $61.00 per share (the “Offering Price”), less underwriting discounts and commissions (the “Offering”).

Filing page SEC filing

Source: SEC EDGAR

accession 0001213900-26-016812

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.